Latest News
Researchers have identified a novel mechanism by which cells die in Alzheimer’s disease, which my aid future therapies targeting cell loss in the brain.
Three-dimensional structural images of the AMPA receptor have been captured for the first time, offering researchers possible new insights into the exact role of this receptor during excitatory neurotransmission.
Researchers discover a potential approach to prevent the progression of many neurological diseases.
Journal Articles
This communication examines the association between the number of seizures in refractory epileptic patients and potential interactions between their antiepileptic medications and single nucleotide polymorphisms.
The goal of this study was to test the state of methylation of transcription start positions in DNA that are actively involved in transcription.
This study generates a novel dataset of associations for disorders such as major depression and schizophrenia, providing a global perspective for their genetic etiology.
Autoimmune
Parkinson’s is partly an autoimmune disease, new study states
Autoantibodies in neurological disorders – a review from Judith Greer
Cerebrovascular disease
CNS/PNS/SNS
Q&A follow-up: Drugs and Driving: Discussing the cognitive effects of drugs on driving performance
New cerebrospinal fluid biomarkers in Alzheimer’s disease
EAN 2017: Guillain-Barré syndrome risk associated with month of birth
Cognitive/neurodegenerative disorders
Researchers identify a novel pathway linked to cell death in Alzheimer’s disease
Glutamate signalling in the brain: first three-dimensional images capture AMPA in action
High prevalence of CTE observed in deceased American football players
Demyelinating disease
Human herpes virus 6 may hamper the brain's ability to repair damaged cells
Development and pediatrics
DNA methylation and transcription onset in the brain
Small-molecule BDNF mimetic may improve symptoms of Rett syndrome
Technological advances in pediatric epilepsy surgery: implications for tuberous sclerosis complex
Epilepsy and seizure
Technological advances in pediatric epilepsy surgery: implications for tuberous sclerosis complex
Epilepsy drug receives approval as monotherapy from European Medicines Agency
Genetics
NCTalks at AAIC 2017: Julie Williams on Alzheimer’s genetics
DNA methylation and transcription onset in the brain
Small-molecule BDNF mimetic may improve symptoms of Rett syndrome
Headache
EAN 2017: Monoclonal antibody could be an effective treatment for chronic migraine
EAN 2017: Cannabinoids suitable for migraine prophylaxis
Noninvasive brain stimulation: an interview with Eric Wasserman
Immune disorders and inflammation
EAN 2017: Guillain-Barré syndrome risk associated with month of birth
Parkinson’s is partly an autoimmune disease, new study states
Infection
NS1-based Zika vaccine demonstrates promise in mice
Zika virus to be investigated as novel glioblastoma treatment
Injury/trauma
High prevalence of CTE observed in deceased American football players
Novel inflammatory biomarkers could lead to an effective diagnostic test for TBI
Movement disorders
NCTalks with Jerrold Vitek: Parkinson's, neuromodulation and collaboration
Parkinson’s disease: asparagine endopeptidase as a potential drug target
EAN 2017: Guillain-Barré syndrome risk associated with month of birth
Neuro-ophthalmology
Management of glaucoma as a neurodegenerative disease
Genetic analysis identifies loci associated with macular telangiectasia type 2
The best of 2016 on Neurology Central – a note from the Editor
Neurometabolic
Could the gut microbiome hold the key to neurodegenerative disorders?
The best of 2016 on Neurology Central – a note from the Editor
Energy drinks and alcohol may affect adolescent brains in similar way to cocaine
Neuromuscular
Novel discovery in motor neuron disease may pave the way for future treatments
EAN 2017: Guillain-Barré syndrome risk associated with month of birth
Neuropsychiatry
NCTalks at AAIC 2017: Megan Zuelsdorff on lifetime stress, racial disparities and cognitive health
Neurotransmitter receptor genotypes associated with mental and behavioral disorders
Is a polygenic predictor of antidepressant response a possibility?
Oncology/tumor
Role of cellular prion protein in neurofibromatosis 2 tumor development uncovered
Alzheimer’s disease patients may have a lower risk of developing lung cancer
Neuroblastoma detected by novel biomarker assay with increased sensitivity
Pain
EAN 2017: Monoclonal antibody could be an effective treatment for chronic migraine
EAN 2017: Cannabinoids suitable for migraine prophylaxis
Recent advances in spinal cord stimulation for pain treatment
Sleep
Poor sleep quality associated with presence of Alzheimer’s disease biomarkers
Light, sleep and circadian rhythms in older adults with Alzheimer's disease and related dementias
#NCintroduces… Mammalian chronobiology and circadian rhythms